Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Rare, but important chronic liver diseases].

K P Maier1

  • 1Medizinische Klinik, Fachbereich Gastroenterologie, Städtische Kliniken Esslingen, Akademisches Lehrkrankenhaus der Universität Tübingen.

Praxis
|January 2, 2003
PubMed
Summary

Non-alcoholic steatohepatitis (NASH), Wilson disease, and hereditary hemochromatosis (HH) are distinct liver conditions. Diagnosis involves excluding other diseases, and treatments vary from lifestyle changes to lifelong medication.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Iron, HCV and the liver.

World journal of gastroenterology·2016
Same author

[Are there therapeutic approaches of non-alcoholic fatty liver disease and its complications?].

Der Internist·2008
Same author

[Ascites].

Praxis·2008
Same author

[Non-alcoholic steatohepatitis--a new epidemic].

Praxis·2007
Same author

[Diverticulosis--diverticulitis].

Praxis·2007
Same author

[Non-alcoholic liver disease (NASH)].

Praxis·2006

Area of Science:

  • Hepatology
  • Genetic Metabolic Disorders
  • Gastroenterology

Background:

  • Non-alcoholic steatohepatitis (NASH) is diagnosed via liver biopsy showing steatosis and inflammation, often linked to obesity and diabetes.
  • Wilson disease is an autosomal recessive copper storage disorder with reduced biliary copper excretion, presenting symptoms typically between ages 6-15.
  • Hereditary hemochromatosis (HH) is a common autosomal recessive iron overload disorder, usually manifesting symptoms between 20-50 years, frequently affecting the liver.

Purpose of the Study:

  • To differentiate the diagnostic criteria and management of NASH, Wilson disease, and HH.
  • To highlight the importance of liver biopsy in NASH diagnosis.
  • To emphasize the genetic basis and diagnostic markers for Wilson disease and HH.

Main Methods:

  • Review of diagnostic features including liver biopsy findings, serum markers, and genetic testing.
  • Differential diagnosis considerations for each condition.
  • Description of established and preliminary treatment strategies.

Main Results:

  • NASH diagnosis is by exclusion, with risk factors including obesity and diabetes; treatment is evolving.
  • Wilson disease diagnosis confirmed by low serum ceruloplasmin, high urinary copper, and elevated liver copper content; lifelong anti-copper therapy is essential.
  • HH diagnosis relies on elevated serum ferritin and transferrin saturation, often linked to HFE gene mutations; phlebotomy is the primary lifelong treatment.

Conclusions:

  • Accurate diagnosis of NASH, Wilson disease, and HH requires specific clinical, biochemical, and histological evaluations.
  • Early diagnosis and appropriate management are crucial for preventing disease progression and complications like cirrhosis and hepatocellular carcinoma (HCC).
  • Treatment strategies are condition-specific, ranging from lifestyle modifications and medication to procedures like phlebotomy.

Related Experiment Videos